RE:IR comes in so many forms ; - ) ...A few mistakes ..corrected now!
I'm just glad we had MODs available so that SOFA could be shelved for a decade + or so. during our development phase.
Didn't David's partner develop MODSs? ...it is a small world id-ent it? Who might be in charge of this TIGRIS deal? Surely not some anonymous consultant with no available or recognizable ties to the company? Another good question for the "BullBoared Help"...they do appear a little dunse when it comes to company knowledge ; - )
I'm more intetested in the Phase 2 Euphas trial that we managed to avoid as a ticker symbol and diagnostic provider.
Shouldn't the design captain of the phase 3 have followed the phase 2 blue-print? That must be water from another river saled under another bridge ( but only to a select few ) and then banked for future reference.
I wonder if the knewest effort here on the rogue social media network is connected to the last act of desperation when stories of Birch Hill selling were strategically circulated and directed out just prior to the move to 15 cents to fortunately make all swell with the 32 cent offering to special people and special AMericans...we are special aren't oui.
Focus on the FAILED phase 3 and the special-tral interview the morning of October 3rd 2016 with Reuters, whilst our investment "appeared to implode" with a 1 penny bid / ask despite the Dialco development and now of course the incredible "Deep Data Dive" and the pending recognition of the EAA to launch a "potential" Canadien "Precision Medicine Campaign? I'll bet "Arsistoltle" stands at the ready... wink wink ; - )
I would mostly read and understand this..IMHO, it is indeed important;
So let's get this straight.... now the FAILED phase 3 Euphrates trial formulates a 75% weighting in a FDA phase 3B confirmatory trial where 2 of every 3 patients in a critical care setting with a primary endpoint of 28 day mortality ACTUALLY get the FAILED device from the phase 3. REALLY? What is next, do we spin $5M USD from a major pharma like say, Baxter into a liability and print 100M shares with the precision of an insider based "personalized investment program" When does 60 Minutes do a full hour on this one? Nevermind 15 minutes on experimental Exthera, this has waaay more cache baby!... it has cache up the ying-yang, where the ying-yang-ed is the retail invester.
There is a reason you were told not to put money in your mouth as a kid...it is very dirty...especially the BIG bills..cuz people like to keep them on the outside so to look prosperous.